Hipra: We are pleased to announce the launch of our new Hipradermic^® website!

A website entirely devoted to our intradermal needle free device for swine vaccination, Hipradermic^®.

It’s 5 years since our first Hipradermic^® version was launched in 2016, with our first intradermal vaccine UNISTRAIN^® PRRS ID. With the advent of MHYOSPHERE^® PCV ID in 2020, we introduced onto the market the latest Hipradermic^® version, Hipradermic^® 3.0, the lightest intradermal needle free device for precise, easy and quick swine vaccination.

Over the last months, we have worked hard to create a website to bring together the most relevant information about Hipradermic^®, the benefits of intradermal needle free vaccination and HIPRAlink^® Vaccination, our vaccination data software management.

Regular updates with the latest news, videos, scientific and technical publications will be available within the Hipradermic^® blog section. You will be also able to subscribe to the newsletter so as not to miss any of these updates!

Hope you like it and enjoy browsing through the Hipradermic^® website: https://hipradermic.com/

July 26, 2021 - Hipra

Article Comments

This area is not intended to be a place to consult authors about their articles, but rather a place for open discussion among pig333.com users.

Leave a new Comment

Access restricted to 333 users. In order to post a comment you must be logged in.

You are not subscribed to this list pig333.com in 3 minutes

Weekly newsletter with all the pig333.com updates

Company HIPRA Spain 17 products 9 Publications 241 Followers

Home

HealthPress releases

The European VAX4ASF project will study next-generation vaccines against ASF

Backed by Horizon Europe and led by HIPRA, the 4-year project bets on the potential of live attenuated vaccines to develop an effective, enduring, and secure solution against ASF virus, contributing to animal welfare, global economic stability, and rural communities.

Home

HealthPress releases

Hipradermic^® 3.0: It’s time to feel the comfort

Hipra has just launched its Hipradermic^® 3.0 device, a new and improved version of Hipradermic^®: an intradermal needle-free jet injector for the vaccination of pigs.

Home

HealthPress releases

COVID-19: HIPRA makes its biotechnology facilities and equipment available

To help deal with the health crisis, the veterinary pharmaceutical company is giving over its new laboratories to hospitals for the analysis of samples and the manufacture of ventilators with 3D printers.